Home › Funds › Clearwater Capital Advisors, LLC › IBRX
Clearwater Capital Advisors, LLC position in IBRX
IMMUNITYBIO INC · Health Care
Clearwater Capital Advisors, LLC reported holding 717,524 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.49% of its reported portfolio and ranking #35 among its reported holdings. Clearwater Capital Advisors, LLC has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Clearwater Capital Advisors, LLC's IBRX position evolved
Clearwater Capital Advisors, LLC first disclosed a stake in IBRX in Q3 2023 at 394,599 shares (US$667K). The position peaked in Q3 2026 at 717,524 shares, worth US$6.8M. Across 13 filings, Clearwater Capital Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 717,524 shares valued at US$6.8M. Notable position changes include a 75% increase in Q4 2024 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 394.60K | $666.87K | New |
| Q4 2023 | 443.30K | $2.23M | Add |
| Q1 2024 | 443.30K | $2.38M | Hold |
| Q2 2024 | 482.55K | $3.05M | Add |
| Q3 2024 | 482.55K | $1.80M | Hold |
| Q4 2024 | 846.42K | $2.17M | Add |
| Q1 2025 | 846.42K | $2.55M | Hold |
| Q2 2025 | 846.42K | $2.23M | Hold |
| Q3 2025 | 846.42K | $2.08M | Hold |
| Q4 2025 | 845.08K | $1.67M | Hold |
| Q1 2026 | 717.52K | $5.50M | Reduce |
| Q2 2026 | 717.52K | $6.28M | Hold |
| Q3 2026 | 717.52K | $6.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBRX and 13F data
IBRX (IMMUNITYBIO INC) is a Health Care company. 66 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), ALLEN HOLDING INC /NY (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBRX
- GREAT POINT PARTNERS LLC 3.00M sh · $26.27M · Q2 2026
- Sound Capital Solutions LLC 1.12M sh · $9.81M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K sh · $6.49M · Q3 2026
- Kercheville Advisors, LLC 613.38K sh · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K sh · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K sh · $4.21M · Q3 2026
More on Clearwater Capital Advisors, LLC
FAQ
How long has Clearwater Capital Advisors, LLC held IBRX?
Clearwater Capital Advisors, LLC has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Clearwater Capital Advisors, LLC's current position in IBRX?
As of Q3 2026, Clearwater Capital Advisors, LLC holds 717.52K shares of IBRX (IMMUNITYBIO INC), valued at $6.77M, representing 0.49% of its reported portfolio and ranking #35.
Has Clearwater Capital Advisors, LLC been buying or selling IBRX?
In the latest 13F filing (Q3 2026), Clearwater Capital Advisors, LLC held unchanged its position in IBRX. The position peaked in Q3 2026 at 717.52K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, ALLEN HOLDING INC /NY, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.